
NIH bid to tackle reproducibility crisis – is data sharing the answer?
Read about the upcoming NIH requirement to include a data management and sharing plan in all grant applications for projects collecting scientific data.
A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Read about the upcoming NIH requirement to include a data management and sharing plan in all grant applications for projects collecting scientific data.
Read about Cochrane reviewers’ approaches to detecting and tackling potential fraud in clinical trial publications.
Read about the proposed actions to increase social justice in scientific publishing.
Read about the pros and cons of disclosing reviewer identities as part of the open review process.
Preprints have changed the way that authors can receive feedback on their manuscript; but when does it verge on ‘unethical’ duplicate peer review?
Missed the meeting? Read our report to get up to speed!
Learn why one expert thinks it’s time to assume all clinical research is fraudulent until there is evidence to the contrary.
Find out how research published in Registered Reports compares to that in standard articles – is it really higher quality?
Read the results of a pilot study on the impact of data availability statements on publication workflows.
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
Nature analyses the ongoing battle publishers are facing against paper mills and what editors are doing to identify these fake articles.
European countries can’t agree on what counts as research misconduct, creating potential pitfalls for researchers.
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.